Trivose 1mg/500mg/0.3mg Tablet ER
Marketer
Salud Care India Pvt Ltd
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Voglibose (0.3mg)
Overview Trivose 1mg/500mg/0.3mg Tablet ER
Diabex-Trio 1mg/500mg/0.3mg Extended-Release Tablets are classified as antidiabetic medications. This combination therapy is indicated for managing type 2 diabetes in adults, effectively regulating blood glucose. Diabex-Trio should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, increasing the risk of complications such as kidney impairment, vision loss, neuropathy, and limb amputation. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle adjustments are pivotal in diabetes control. The most prevalent adverse effect is hypoglycemia (low blood sugar). Familiarize yourself with hypoglycemia symptoms (e.g., sweating, lightheadedness, headache, tremor) and appropriate countermeasures. Regular meals and readily available glucose sources (e.g., sweets, juice) are essential. Alcohol consumption should be limited due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, cephalalgia, edema, blurred vision, bone fractures, and upper respiratory infections. Weight gain may occur. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Consult your doctor prior to use during pregnancy or breastfeeding. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to assess blood cell counts and liver function.
Primary Ingredients of Trivose 1mg/500mg/0.3mg Tablet ER
The provided text is "undefined," so no rephrasing is possible.
Uses of Trivose 1mg/500mg/0.3mg Tablet ER
Managing type 2 diabetes
Major Benefits of Trivose 1mg/500mg/0.3mg Tablet ER:
Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment period. Ingest the entire tablet without chewing, crushing, or dividing it. Administer Trivose 1mg/500mg/0.3mg Extended-Release Tablet on an empty stomach.
Common Side effects of Trivose 1mg/500mg/0.3mg Tablet ER:
- Nausea
- Diarrhea
- Abdominal pain
- Hypoglycemia (low blood glucose level)
- Loss of appetite
How to use Trivose 1mg/500mg/0.3mg Tablet ER:
Follow your physician's instructions precisely regarding dosage and treatment length for this medication. Ingest the Trivose 1mg/500mg/0.3mg Extended-Release tablet whole; avoid chewing, crushing, or breaking it. Administer on an empty stomach.
How Trivose 1mg/500mg/0.3mg Tablet ER works:
Extended-release Trivose tablets (1mg/500mg/0.3mg) contain a triple-action antidiabetic formulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Trivose 1mg/500mg/0.3mg ER tablets with alcohol is dangerous.
PregnancyCONSULT YOUR DOCTOR
Extended-release Trivose tablets (1mg/500mg/0.3mg) might pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Trivose tablets (1mg/500mg/0.3mg) are likely not safe for use while breastfeeding. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Impaired driving is a possibility if your blood glucose levels are abnormally low or elevated. Refrain from driving should such symptoms arise.
KidneyUNSAFE
Patients with kidney disease should likely avoid Trivose 1mg/500mg/0.3mg Tablet ER, as its use may be unsafe. A physician's consultation is advised. Furthermore, Trivose 1mg/500mg/0.3mg Tablet ER is not recommended for individuals with severe kidney impairment.
LiverCAUTION
Patients with liver impairment should use Trivose 1mg/500mg/0.3mg Extended-Release tablets cautiously, potentially requiring dosage modification. Medical advice is recommended. In individuals with mild to moderate hepatic dysfunction, initiation with a reduced Trivose 1mg/500mg/0.3mg Extended-Release tablet dose is typical; however, its use is contraindicated in those with severe liver disease.
What if you forget to take Trivose 1mg/500mg/0.3mg Tablet ER :
Should you forget a Trivose 1mg/500mg/0.3mg Extended-Release tablet, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Trivose 1mg/500mg/0.3mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Medication |
3,018 People bought this recently